SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export

被引:26
|
作者
Hall, Ross [1 ]
Guedan, Anabel [1 ]
Yap, Melvyn W. [1 ]
Young, George R. [2 ]
Harvey, Ruth [3 ]
Stoye, Jonathan P. [4 ,5 ]
Bishop, Kate N. [1 ]
机构
[1] Francis Crick Inst, Retroviral Replicat Lab, London, England
[2] Francis Crick Inst, Bioinformat & Biostat STP, London, England
[3] Francis Crick Inst, World Influenza Ctr, London, England
[4] Francis Crick Inst, Retrovirus Host Interact Lab, London, England
[5] Imperial Coll London, Dept Infect Dis, London, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
NUCLEAR EXPORT; LENTIVIRAL VECTOR; MATRIX PROTEIN; RIG-I; GENE; IRF-1; EXPRESSION; NUP98; RAE1; ACTIVATION;
D O I
10.1371/journal.ppat.1010349
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2 is a betacoronavirus and the etiological agent of COVID-19, a devastating infectious disease. Due to its far-reaching effect on human health, there is an urgent and growing need to understand the viral molecular biology of SARS-CoV-2 and its interaction with the host cell. SARS-CoV-2 encodes 9 predicted accessory proteins, which are presumed to be dispensable for in vitro replication, most likely having a role in modulating the host cell environment to aid viral replication. Here we show that the ORF6 accessory protein interacts with cellular Rae1 to inhibit cellular protein production by blocking mRNA export. We utilised cell fractionation coupled with mRNAseq to explore which cellular mRNA species are affected by ORF6 expression and show that ORF6 can inhibit the export of many mRNA including those encoding antiviral factors such as IRF1 and RIG-I. We also show that export of these mRNA is blocked in the context of SARS-CoV-2 infection. Together, our studies identify a novel mechanism by which SARS-CoV-2 can manipulate the host cell environment to supress antiviral responses, providing further understanding to the replication strategies of a virus that has caused an unprecedented global health crisis.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern
    Caobi, Allen
    Saeed, Mohsan
    CURRENT OPINION IN MICROBIOLOGY, 2024, 79
  • [32] Binding affinities analysis of ivermectin, nucleocapsid and ORF6 proteins of SARS-CoV-2 to human importins α isoforms: A computational approach
    Gayozo, Elvio
    Rojas, Laura
    Barrios, Julio
    BIOTECNIA, 2025, 27
  • [33] SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
    Miorin, Lisa
    Kehrer, Thomas
    Sanchez-Aparicio, Maria Teresa
    Zhang, Ke
    Cohen, Phillip
    Patel, Roosheel S.
    Cupic, Anastasija
    Makio, Tadashi
    Mei, Menghan
    Moreno, Elena
    White, Kris M.
    Rathnasinghe, Raveen
    Uccellini, Melissa
    Gao, Shengyan
    Aydillo, Teresa
    Mena, Ignacio
    Yin, Xin
    Martin-Sancho, Laura
    Krogan, Nevan J.
    Chanda, Sumit K.
    Schotsaert, Michael
    Wozniak, Richard W.
    Ren, Yi
    Rosenberg, Brad R.
    Fontoura, Beatriz M. A.
    Garcia-Sastre, Adolfo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (45) : 28344 - 28354
  • [34] Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination
    Theobald, Sebastian J.
    Simonis, Alexander
    Mudler, Julie M.
    Goebel, Ulrike
    Acton, Richard
    Kohlhas, Viktoria
    Albert, Marie-Christine
    Hellmann, Anna-Maria
    Malin, Jakob J.
    Winter, Sandra
    Hallek, Michael
    Walczak, Henning
    Phuong-Hien Nguyen
    Koch, Manuel
    Rybniker, Jan
    EMBO MOLECULAR MEDICINE, 2022, 14 (08)
  • [35] Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
    Mairhofer, Mario
    Kausche, Lea
    Kaltenbrunner, Sabine
    Ghanem, Riad
    Stegemann, Maike
    Klein, Katharina
    Pammer, Maria
    Rauscher, Isabella
    Salzer, Helmut J. F.
    Doppler, Stefan
    Habringer, Anna
    Paar, Christian
    Kimeswenger, Susanne
    Hoetzenecker, Wolfram
    Lamprecht, Bernd
    Lee, Soyoung
    Schmitt, Clemens A.
    CANCER CELL, 2021, 39 (09) : 1171 - 1172
  • [36] SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy
    Li, Xingyu
    Hou, Peili
    Ma, Wenqing
    Wang, Xuefeng
    Wang, Hongmei
    Yu, Zhangping
    Chang, Huasong
    Wang, Tiecheng
    Jin, Song
    Wang, Xue
    Wang, Wenqi
    Zhao, Yudong
    Zhao, Yong
    Xu, Chunqing
    Ma, Xiaomei
    Gao, Yuwei
    He, Hongbin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (01) : 67 - 78
  • [37] Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France
    Queromes, Gregory
    Destras, Gregory
    Bal, Antonin
    Regue, Hadrien
    Burfin, Gwendolyne
    Brun, Solenne
    Fanget, Remi
    Morfin, Florence
    Valette, Martine
    Trouillet-Assant, Sophie
    Lina, Bruno
    Frobert, Emilie
    Josset, Laurence
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 167 - 177
  • [38] SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy
    Xingyu Li
    Peili Hou
    Wenqing Ma
    Xuefeng Wang
    Hongmei Wang
    Zhangping Yu
    Huasong Chang
    Tiecheng Wang
    Song Jin
    Xue Wang
    Wenqi Wang
    Yudong Zhao
    Yong Zhao
    Chunqing Xu
    Xiaomei Ma
    Yuwei Gao
    Hongbin He
    Cellular & Molecular Immunology, 2022, 19 : 67 - 78
  • [39] Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b
    Garcia-Garcia, Transito
    Fernandez-Rodriguez, Raul
    Redondo, Natalia
    de Lucas-Rius, Ana
    Zaldivar-Lopez, Sara
    Lopez-Ayllon, Blanca Dies
    Suarez-Cardenas, Jose M.
    Jimenez-Marin, Angeles
    Montoya, Maria
    Garrido, Juan J.
    ISCIENCE, 2022, 25 (11)
  • [40] Chemical Exposures Affect Innate Immune Response to SARS-CoV-2
    Arowolo, Olatunbosun
    Pobezinsky, Leonid
    Suvorov, Alexander
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)